Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. R. Hande
The Pharmacokinetics and Safety of ABT-751, a Novel, Orally Bioavailable Sulfonamide Antimitotic Agent: Results of a Phase 1 Study
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Study
PLoS ONE
Multidisciplinary
Safety, Tolerability, and Pharmacokinetics of the Novel Anti-Influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings
Clinical Drug Investigation
Medicine
Pharmacology
A Phase 1 Trial to Assess the Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics of a Novel Dapivirine Vaginal Film
Journal of Acquired Immune Deficiency Syndromes
Infectious Diseases
Pharmacology
In Vitro Antiviral Activity and Single-Dose Pharmacokinetics in Humans of a Novel, Orally Bioavailable Inhibitor of Human Rhinovirus 3C Protease
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women With HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study
Infectious Diseases and Therapy
Infectious Diseases
Microbiology
Response to Comments on “Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-In-Human Phase I Study”
Clinical Drug Investigation
Medicine
Pharmacology
Fragment-Based Drug Design and Identification of HJC0123 , a Novel Orally Bioavailable STAT3 Inhibitor for Cancer Therapy
European Journal of Medicinal Chemistry
Medicine
Organic Chemistry
Drug Discovery
Pharmacology
Tert-Butylphenylthiazoles With an Oxadiazole Linker: A Novel Orally Bioavailable Class of Antibiotics Exhibiting Antibiofilm Activity
RSC Advances
Chemistry
Chemical Engineering
The Phase 1 Study of Bucumolol, a New Β-Blocking Agent
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
